Wednesday, July 8, 2026

biotech · Clostridium Difficile Infection · Autism Spectrum Disorder · FNCHQ

Finch Therapeutics Group

Finch Therapeutics Group clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Somerville, USA HQ
15 Employees
Public company Type
FNCHQ · NYSE Ticker
Company details
Status
Public
HQ
Somerville, USA
Employees
15
Programs
5
Drugs
2
Patents
33
Intelligence · Clinical Programs

Finch Therapeutics Group projects

1 ClinicalTrials.gov programs sponsored by Finch Therapeutics Group.

Finch Therapeutics Group has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Fecal Microbiota Transplantation

    Finch Therapeutics Group

    Enterobacteriaceae Infections

    phase 1 mab terminated

    1 trial

Frequently asked questions

How many clinical projects does Finch Therapeutics Group have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.